VanEck Associates’s Allergan Inc AGN Stock Holding History

VanEck Associates’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-70,561	Closed	-$15M	–	799
2014 Q4	$15M	Sell	70,561 -20,477	-22%	-$4.07M	0.09%	167
2014 Q3	$16.2M	Sell	91,038 -1,838	-2%	-$305K	0.09%	165
2014 Q2	$15.7M	Sell	92,876 -17,481	-16%	-$2.72M	0.07%	165
2014 Q1	$13.7M	Buy	110,357 +3,932	+4%	+$479K	0.07%	173
2013 Q4	$11.8M	Sell	106,425 -221,044	-68%	-$21.1M	0.06%	175
2013 Q3	$29.6M	Buy	327,469 +219,406	+203%	+$19.7M	0.15%	98
2013 Q2	$9.1M	Buy	+108,063	New	+$11.2M	0.05%	172

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

VanEck Associates's AGN Position: Q1 2015 in Review

VanEck Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 70,561 shares — an estimated $15M sold.

VanEck Associates first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $29.6M in Q3 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

VanEck Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
VanEck Associates sold 70,561 Allergan Inc shares in Q1 2015, an estimated $15M.
VanEck Associates first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
VanEck Associates's Allergan Inc position peaked at $29.6M in Q3 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on VanEck Associates's 13F filing for Q1 2015, filed 14 May 2015.